"Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo."@nl . . . . "v\u011Bdeck\u00FD \u010Dl\u00E1nek"@cs . "Bruna Corominas-Faja" . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Rosa Bonavia" . "wetenschappelijk artikel"@nl . . . "artigo cient\u00EDfico"@pt . . . . . . . . . . . . "256074437" . . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@en . . . . . . . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0441\u0456\u0447\u043D\u0456 2013"@uk . . . . . . . . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@en . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo."@nl . . . . . . . "3" . . . . . . "Joana Visa" . . . . . . . . . "videnskabelig artikel"@da . . . . "\u043D\u0430\u0443\u0447\u043D\u0438 \u0447\u043B\u0430\u043D\u0430\u043A"@sr . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@ast . . . . . "Antonio Segura-Carretero" . . . . . . "articolo scientifico"@it . . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@en . . . . . . . . . . "Cristina Oliveras-Ferraros" . . . . "3748425" . "wissenschaftlicher Artikel"@de . . . . "2013-01-01T00:00:00Z"^^ . . . . . . . "23963283" . . . . "article scientifique"@fr . . "S\u00EDlvia Cuf\u00ED" . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2013"@ast . . "article cient\u00EDfic"@ca . . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 \u0646\u0634\u0631\u062A \u0641\u064A \u064A\u0646\u0627\u064A\u0631 2013"@ar . . . . . . . . . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo."@nl . "bilimsel makale"@tr . . . . "Alejandro Vazquez-Martin" . . "2459" . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@ast . . . . . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@en . "vedeck\u00FD \u010Dl\u00E1nok"@sk . . . . . "10.1038/SREP02459" . . . . . . . . . . . . . "scientific article published on January 2013"@en . . "vetenskaplig artikel"@sv . . . . . . . . . . . . . . . . . . . . "Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo"@ast . . . . .